Profile
Andrea Spezzi was the founder of Orchard Therapeutics Plc, founded in 2008, where she held the title of Chief Medical Officer.
She is also the founder of Rejuvitas, Inc., founded in 2021, where she currently holds the titles of President, Chief Executive Officer & Director.
Additionally, Dr. Spezzi was the founder of Orchard Therapeutics (Europe) Ltd., founded in 2015, where she held the title of Chief Medical Officer until 2021.
Dr. Spezzi's current job is as an Independent Director at Bloomsbury Genetic Therapies Ltd., starting in 2022.
Dr. Spezzi's former jobs include being a Senior Medical Director at GSK Plc and a Global Medical Director at Takeda Pharmaceutical Co., Ltd.Dr. Spezzi's education history includes an undergraduate degree from Universidad de Buenos Aires.
Andrea Spezzi active positions
| Companies | Position | Start |
|---|---|---|
Rejuvitas, Inc.
 Rejuvitas, Inc. BiotechnologyHealth Technology Rejuvitas, Inc. provides biotechnology services. The company is based in Nissequogue, NY. The company was founded by Andrea Spezzi. Andrea Spezzi has been the CEO since incorporation. | Founder | 2021-11-30 |
Bloomsbury Genetic Therapies Ltd.
 Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | Director/Board Member | 2022-09-30 |
Former positions of Andrea Spezzi
| Companies | Position | End |
|---|---|---|
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Founder | 2021-08-31 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Chief Tech/Sci/R&D Officer | - |
| GSK PLC | Chief Tech/Sci/R&D Officer | - |
| ORCHARD THERAPEUTICS PLC | Founder | - |
Training of Andrea Spezzi
| Universidad de Buenos Aires | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
Rejuvitas, Inc.
Rejuvitas, Inc. BiotechnologyHealth Technology Rejuvitas, Inc. provides biotechnology services. The company is based in Nissequogue, NY. The company was founded by Andrea Spezzi. Andrea Spezzi has been the CEO since incorporation. | Health Technology |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | Health Technology |
- Stock Market
- Insiders
- Andrea Spezzi
